Destiny Pharma PLC
LSE:DEST
Income Statement
Earnings Waterfall
Destiny Pharma PLC
Revenue
|
0
GBP
|
Operating Expenses
|
-7.2m
GBP
|
Operating Income
|
-7.2m
GBP
|
Other Expenses
|
1.2m
GBP
|
Net Income
|
-6m
GBP
|
Income Statement
Destiny Pharma PLC
Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||||||||
Operating Expenses |
(3)
|
0
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(6)
|
(7)
|
(8)
|
(7)
|
|
Selling, General & Administrative |
(2)
|
0
|
(3)
|
(6)
|
(2)
|
(6)
|
(2)
|
(7)
|
(3)
|
(7)
|
(3)
|
(8)
|
|
Research & Development |
(1)
|
0
|
(3)
|
0
|
(4)
|
0
|
(4)
|
0
|
(4)
|
0
|
(5)
|
0
|
|
Depreciation & Amortization |
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Operating Income |
(3)
N/A
|
0
N/A
|
(6)
N/A
|
(6)
+4%
|
(6)
+7%
|
(6)
-10%
|
(7)
-8%
|
(7)
-1%
|
(6)
+4%
|
(7)
-13%
|
(8)
-9%
|
(7)
+7%
|
|
Pre-Tax Income | |||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(3)
N/A
|
0
N/A
|
(6)
N/A
|
(6)
+3%
|
(6)
+6%
|
(6)
-9%
|
(6)
-7%
|
(7)
0%
|
(6)
+4%
|
(7)
-13%
|
(8)
-9%
|
(7)
+9%
|
|
Net Income | |||||||||||||
Tax Provision |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Income from Continuing Operations |
(3)
|
0
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(7)
|
(6)
|
|
Net Income (Common) |
(3)
N/A
|
0
N/A
|
(5)
N/A
|
(5)
+4%
|
(5)
+6%
|
(5)
-7%
|
(5)
-7%
|
(5)
-1%
|
(5)
+2%
|
(6)
-13%
|
(7)
-8%
|
(6)
+8%
|
|
EPS (Diluted) |
-0.08
N/A
|
0
N/A
|
-0.12
N/A
|
-0.11
+8%
|
-0.11
N/A
|
-0.11
N/A
|
-0.12
-9%
|
-0.11
+8%
|
-0.09
+18%
|
-0.1
-11%
|
-0.09
+10%
|
-0.08
+11%
|